U.S. Markets close in 2 hrs 54 mins

ImmunoGen, Inc. (IMGN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.21+0.21 (+3.00%)
As of 1:06PM EDT. Market open.
People also watch
SGENIMMUEXELINCYCLDX
  • Told ya short squeeze
  • Not being cocky, because shorts have been right about this stock waaaaaay more than longs, but I would not want to be carrying a short position on this stock now. If you are short, and you were not busily closing it out as this thing traded down near $1.50 a while back....well, I just don't know.....and that's all I got to say about that......
  • 7 here we come no time for pullbacks lock n load
  • Let's go 8!
  • It is taking off! Cheers to longs!
  • 8 are gonna be easy I was loading in the 6's over a year ago
  • Up 70% so far but need more shares! Hoping it pulls back a bit. Geez, it was 4.60 two weeks ago when I last bought.
  • IMGN is up 11.72% to 6.77
  • Harry Boxer has posted his Charts of the Day video on IMGN at TheTechTrader site noting: ImmunoGen, Inc. (IMGN), one of our swing trades is doing great, popping 46 cents, or 7%, to 7.00, on 3.9 million shares traded, reaching up to 7.10. That was a nice move to the top of the channel and I think it still has time to go. I’m looking for 8 1/2 and 9 3/4 going forward. It has 9.2 days to cover.
  • If you missed the boat (like I've been warning ya), check RAD.
  • Looks like every short within the past year is underwater. Institutions are purchasing (net result). Short squeeze about to push this puppy into double digits.

    Shares Outstanding: 89.35M
    Float: 81.09M
    % Held by Insiders: 0.36%
    % Held by Institutions: 91.70%
    Shares Short: 12.74M
    Short % of Float: 17.94%
    Shares Short (prior month): 13.61M

    http://www.nasdaq.com/symbol/imgn/institutional-holdings

    HOLDERS..............................SHARES
    Increased Positions (55).........6,972,570
    Decreased Positions (74)........6,532,455
    Held Positions (39)..................54,088,762
    Total Institutional Shares (168)...67,593,787

    New and Sold Out Positions (Institutional):

    New Positions (17): 4,685,978
    Sold Out Positions (34): 2,100,902

    ImmunoGen, Inc. (IMGN) Institutional Ownership & Holdings
    Detailed institutional ownership and holders of ImmunoGen, Inc. (IMGN), including new, increased, descreased, and sold out positions.
    www.nasdaq.com
  • great run. great pipeline. m u only concern is they are quickly running out of cash and will issue dilution stock offering very soon.
  • It is unstoppable. Shorts are doomed.
  • awesome but begs the question WHY?
  • Harry Boxer has posted his Charts of the Day video on IMGN at TheTechTrader site noting: ImmunoGen, Inc. (IMGN) is a really nice, low-priced stock. It has a nice channel up, orderly retraces, symmetrical 3-wave to the corrective 50, it held, bounced, and on Monday, it finished up 33 cents, or 7.2%, to 4.91, on 2.1 million shares traded, and through the declining topsline. I’m looking for a quick test on Tuesday of about 5.20, and then a follow-through to 5.53. If it gets through that, we’re looking at a 7-dollar stock.
  • Flying high! Next stop $6.
  • Things won are done; joy's soul lies in the doing. http://dataunion.tistory.com/954

    [2016-MAY] ImmunoGen NASDAQ : IMGN Correlation Histogram
    X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks May-2016 1,000 Day Parameter 2,830 NASDAQ Stocks Price Analysis This stock mode of correlation coefficient is 0.2 In other words, the correlation coefficient of the other stock
    dataunion.tistory.com
  • Maybe IMGN will finally make it big after 25 years of mostly failed attempts. Is this the next big thing, or more false hope. You never know with IMGN, it's hard to believe them after 25 years of BS. I'll be sad if they finally make it big and I'm not on board, should have bought low. Best of luck IMGN longs.
  • June 23rd you will find out about the clinical trials( 110 trial performed to date, huge success on late stage cancer patients ) of possibly a ground breaking cancer drug, there are a dozen companies in the mix, but only a few with the proper third paten. there will be distribution deals and mergers and buy-outs. Not sure how IMGN will fair, but they will get royalties
  • IMGN reached a new 52 Week High at 5.59